title: Further questions regarding the role of mosaic penA sequences in conferring reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae.
authors.forename: David M
authors.initials: DM
authors.lastname: Whiley
authors.forename: E Athena
authors.initials: EA
authors.lastname: Limnios
authors.forename: Sanghamitra
authors.initials: S
authors.lastname: Ray
authors.forename: Theo P
authors.initials: TP
authors.lastname: Sloots
authors.forename: John W
authors.initials: JW
authors.lastname: Tapsall
mesh_terms: D000595:Amino Acid Sequence; D002443:Ceftriaxone / Q000494:pharmacology*; D024881:Drug Resistance, Bacterial / Q000235:genetics; D005260:Female; D005798:Genes, Bacterial; D006069:Gonorrhea / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D009344:Neisseria gonorrhoeae / Q000187:drug effects / Q000235:genetics; D016415:Sequence Alignment; D017421:Sequence Analysis
chemical_list: D002443:Ceftriaxone